Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03061526
Other study ID # EK 417102016
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 1, 2017
Est. completion date December 2023

Study information

Verified date March 2023
Source Technische Universität Dresden
Contact Egbert Matthé, MD
Phone +493514583381
Email egbert.matthe@uniklinikum-dresden.de
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Retinal vessel occlusions might lead to ischemia of the inner retina, more severe so in artery occlusions. Intracellular edema may develop and decrease transparency of those layers, showing retinal edema. In spectral domain optical coherence tomography (SD-OCT) retinal reflectivity changes as a result of retinal edema. The investigators examine the reflectivity changes of different retinal layers between healthy eyes and eyes with retinal artery occlusion and ischemic or non-ischemic vein occlusions. Aim of the study is to evaluate whether those changes can be used to measure the level of ischemia in the inner retina.


Description:

Several studies tried to classify retinal ischemia due to retinal artery or vein occlusion into different grades. In some cases prognosis is dependent on grade of severity, especially in cases of retinal vein occlusion. State of the art to Diagnose the severity of retinal ischemia is lfuorescein angiography. However, this technique is invasive and might cause Problems like anaphylactic shock. Optical coherence tomography is a non-invasive technique, but up to now there is no standardized method to quantify the grade of severity of retinal ischemia in such conditions like retinal vessel occlusion. The study hope to find criteria by which such a classification can be constructed.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 2023
Est. primary completion date December 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - acute Retinal vessel occlusion on one eye - healthy contralateral eye - examined with spectral Domain optical coherence tomography Exclusion Criteria: - retinal occlusion older than 1 week - OCT Image not obtainable/missing

Study Design


Related Conditions & MeSH terms


Intervention

Other:
optical coherence tomography
measurement of reflectivity in different retinal layers based on optical coherence tomography findings

Locations

Country Name City State
Germany University Eye Hospital Dresden

Sponsors (1)

Lead Sponsor Collaborator
Technische Universität Dresden

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary reflectivity optical density of different retinal layers December 2017
See also
  Status Clinical Trial Phase
Withdrawn NCT03730779 - Oxygen Therapy for Retinal Ischemia Phase 4
Completed NCT03906383 - Changes in the Diameter of Retinal Vessels After Remote Ischemic Conditioning in Patients With Type 1 Diabetes N/A
Active, not recruiting NCT03422965 - Perifoveal Vascular Network Assessed by OCT-Angiography in Type I Diabetes Mellitus N/A
Completed NCT00841373 - Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease Phase 1/Phase 2
Recruiting NCT04038125 - Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME Phase 4